Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | FYN | P06241 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9329422 | 1.00 | LMNA (0.52) | LMNAMAPK1ALOX5LCKFYN | |
| SCHEMBL11520740 | 0.81 | ALOX5 (0.47) | LMNAMAPK1ALOX5LCKFYN | |
| SCHEMBL10759383 | 0.81 | ALOX5 (0.56) | ALOX5LCKFYNDAOCES2 | |
| SCHEMBL14416057 | 0.81 | ALOX5 (0.51) | LMNAMAPK1ALOX5LCKFYN | |
| SCHEMBL18734632 | 0.80 | CYP2D6 (0.50) | LMNAMAPK1ALOX5LCKFYN | |
| SCHEMBL162736 | 0.80 | SRC (0.50) | LMNAMAPK1ALOX5LCKFYN | |
| SCHEMBL14671259 | 0.79 | ALOX5 (0.42) | LMNAMAPK1ALOX5LCKFYN | |
| SCHEMBL18169428 | 0.79 | ALOX5 (0.42) | LMNAMAPK1ALOX5LCKFYN | |
| SCHEMBL6775406 | 0.79 | CES2 (0.63) | LMNAMAPK1ALOX5LCKFYN | |
| Hydrochloric Acid SCHEMBL11244144 | 0.78 | SRC (0.48) | ALOX5LCKFYNDAOCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230277491-A1 | PHARMACEUTICAL COMBINATION COMPRISING GLYCOLIC ACID AND L-ALANINE | PAN MONTOJO FRANCISCO (DE) | 2023-09-07 | — | — | US | disclosed |
| EP-4188358-A2 | PHARMACEUTICAL COMBINATION COMPRISING GLYCOLIC ACID AND L-ALANINE OR PYRUVATE | Pan-Montojo, Francisco (DE) | 2023-06-07 | — | — | EP | disclosed |
| US-20220354808-A1 | GLYCOLIC ACID PROTECTS AGAINST ISCHEMIC INSULTS | PAN MONTOJO FRANCISCO (DE) | 2022-11-10 | — | — | US | disclosed |
| US-11426372-B2 | Glycolic acid protects against ischemic insults | PAN MONTOJO FRANCISCO (DE) | 2022-08-30 | — | — | US | disclosed |
| WO-2022023545-A2 | PHARMACEUTICAL COMBINATION COMPRISING GLYCOLIC ACID AND L-ALANINE | PAN MONTOJO FRANCISCO (DE) | 2022-02-03 | — | — | WO | disclosed |
| EP-3377055-B1 | GLYCOLIC ACID PROTECTS AGAINST ISCHEMIC INSULTS | PAN MONTOJO FRANCISCO (DE) | 2021-10-13 | — | — | EP | disclosed |
| US-20180325849-A1 | GLYCOLIC ACID PROTECTS AGAINST ISCHEMIC INSULTS | PAN MONTOJO FRANCISCO (DE) | 2018-11-15 | — | — | US | disclosed |
| EP-3377055-A1 | GLYCOLIC ACID PROTECTS AGAINST ISCHEMIC INSULTS | Pan-Montojo, Francisco (DE) | 2018-09-26 | — | — | EP | disclosed |
| US-9828594-B2 | Nitrilases, nucleic acids encoding them and methods for making and using them | BASF ENZYMES LLC (US) | 2017-11-28 | — | — | US | disclosed |
| US-20160355801-A1 | NITRILASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | VERENIUM CORPORATION | 2016-12-08 | — | — | US | disclosed |
| EP-0424021-B1 | Antimuscarinic bronchodilators | PFIZER LTD (GB) | 1994-03-02 | — | — | EP | disclosed |
| US-5171744-A | Antimuscarinic bronchodilators | PFIZER INC. (US) | 1992-12-15 | — | — | US | disclosed |
| US-5089490-A | Cephem derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-02-18 | — | — | US | disclosed |
| EP-0424021-A1 | Antimuscarinic bronchodilators | Pfizer Limited (GB) | 1991-04-24 | — | — | EP | disclosed |
| US-4758556-A | Cephem derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-07-19 | — | — | US | disclosed |
| US-4297489-A | CEPHALOSPORINS | BRISTOL-MYERS COMPANY (US) | 1981-10-27 | — | — | US | disclosed |
| US-4278793-A | ANTIBIOTICS, BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-14 | — | — | US | disclosed |
| US-4172196-A | CEPHALOSPORINS | BRISTOL-MYERS COMPANY (US) | 1979-10-23 | — | — | US | disclosed |
| US-4112228-A | BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-3985738-A | ANTIBACTERIAL AGENTS | BRISTOL-MYERS COMPANY (US) | 1976-10-12 | — | — | US | disclosed |